abstract |
A stable liquid formulation that is free of water or has a water content of less than 6% by weight, comprising polyethylene glycol and a sodium or potassium salt of an H + inhibitor, K + -ATPase, and optionally pharmaceutically acceptable excipients that are soluble in the formulation |